Salesforce.comShares of Salesforce.com ( CRM) jumped 7.2% to $143.49 on volume of nearly 800,000, according to Nasdaq.com, after the cloud and software technology company reported non-GAAP earnings of $54.5 million, or 37 cents a share, on revenue of $695.5 million for its fiscal first quarter. The average estimate of analysts polled by Thomson Reuters was for a profit of 34 cents a share on revenue of $678.2 million in the April-ended period. Salesforce.com also forecast non-GAAP earnings of 38 to 39 cents a share for the second quarter ending in July vs. Wall Street's consensus view for a profit of 38 cents a share.
Marvell TechnologyMarvell Technology ( MRVL) was a winner in Thursday's extended session after the Santa Clara, Calif.-based chip maker reported better than expected quarterly results, initiated a dividend and boosted its buyback program. The company reported non-GAAP earnings of $139 million, or 23 cents a share, for the first quarter on revenue of $796.4 million, besting the average analysts' view of for a profit of 20 cents a share on revenue of $768.7 million. Marvell also said its board has approved a quarterly dividend of 6 cents a share and increased its repurchase authorization by $500 million to $2.5 billion. The stock was last quoted at $13.80, up 3.8%. on volume of more than 500,000.
SequenomShares of Sequenom ( SQNM) were down in late trades after the company said Coventry Health Care ( CVH) has opted to terminate a coverage agreement between the two companies. Sequenom said Coventry had opted to terminate the agreement without cause effective August 31, and that it advised that "this decision was not a judgment" on Sequenom or its products. The deal would have provided coverage for Sequenom's MaterniT21 PLUS laboratory-developed test and other similar products within Coventry's network. The stock was last quoted at $4.40, off 7.8%, on volume of nearly 90,000, according to Nasdaq.com.